Phosphorylation-Regulated Binding of RNA Polymerase II to Fibrous Polymers of Low-Complexity Domains  by Kwon, Ilmin et al.
Phosphorylation-Regulated Binding
of RNA Polymerase II to Fibrous Polymers
of Low-Complexity Domains
Ilmin Kwon,1,5 Masato Kato,1,5 Siheng Xiang,1 Leeju Wu,1 Pano Theodoropoulos,1 Hamid Mirzaei,1 Tina Han,1,3
Shanhai Xie,1,4 Jeffry L. Corden,2 and Steven L. McKnight1,*
1Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9152, USA
2Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
3Present address: Department of Physiology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco,
CA 94158, USA
4Present address: Peloton Therapeutics, Dallas, TX 75235, USA
5These authors contributed equally to this work
*Correspondence: steven.mcknight@utsouthwestern.edu
http://dx.doi.org/10.1016/j.cell.2013.10.033SUMMARY
The low-complexity (LC) domains of the products of
the fused in sarcoma (FUS), Ewings sarcoma (EWS),
and TAF15 genes are translocated onto a variety of
different DNA-binding domains and thereby assist
in driving the formation of cancerous cells. In the
context of the translocated fusion proteins, these
LC sequences function as transcriptional activa-
tion domains. Here, we show that polymeric fibers
formed from these LC domains directly bind the
C-terminal domain (CTD) of RNA polymerase II in a
manner reversible by phosphorylation of the iterated,
heptad repeats of the CTD. Mutational analysis indi-
cates that the degree of binding between the CTD
and the LC domain polymers correlates with the
strength of transcriptional activation. These studies
offer a simple means of conceptualizing how RNA
polymerase II is recruited to active genes in its
unphosphorylated state and released for elongation
following phosphorylation of the CTD.INTRODUCTION
Numerous forms of cancer result from translocation events
wherein the amino terminal, low-complexity (LC) domains of
any of three related RNA-binding proteins become fused to a
variety of different DNA-binding domains (Arvand and Denny,
2001; Guipaud et al., 2006; Lessnick and Ladanyi, 2012). The
relevant RNA-binding proteins include the products of the fused
in sarcoma (FUS), Ewings sarcoma (EWS), and TAF15 genes.
Collectively, these three RNA-binding proteins are referred to
as FET (FUS/EWS/TAF15) proteins (Andersson et al., 2008).
The proteins encoded by these varied translocation products
are causative of transformation (Bertolotti et al., 1999; Crozat
et al., 1993; Ichikawa et al., 1999; Rabbitts et al., 1993; ZinsznerCet al., 1994). They further display dual dependency upon both the
DNA-binding domain, which can be represented by members of
thehomeobox, zincfinger, ETS, or leucine zipper families ofDNA-
binding domains, as well as the LC domains donated by FUS,
EWS, or TAF15. The DNA-binding domains are understood to
direct the cancer-causing fusionproteins to appropriate batteries
of genesadequate to facilitate cell growthor survival. Bycontrast,
the LC sequences donated by members of the FET family are
understood to function as transcriptional activation domains.
Over the past several decades the fields of biochemistry,
biophysics, and molecular biology have achieved a concrete un-
derstanding of how DNA-binding domains function. The atomic
structures of many such domains have been resolved by either
X-ray crystallography or NMR spectroscopy, often in complex
with their specific DNA substrates. By contrast, far less is known
about the manner in which transcriptional activation domains
operate at a mechanistic level. Prototypic activation domains
are comprised of low-complexity sequences that exist in an
intrinsically disordered, random coil conformation (Huntley and
Golding, 2002; Uversky, 2002). The observation that evolutionary
pressure of cancer cell formation has repeatedly led to the selec-
tion of the LC domains of FET proteins as the fusion partner to a
variety of different DNA-binding domains strongly hints that
these particular LC sequencesmay be exceptionally potent tran-
scriptional activation domains.
The LC domain of FUS donated to the translocation product
causative of cancer has a highly skewed distribution of amino
acids. Of the 220 residues within the FUS LC domain, 84% are
comprised of only four amino acids—glycine, serine, glutamine,
and tyrosine. The domain contains zero representatives of gluta-
mic acid, lysine, arginine, cysteine, histidine, valine, leucine,
isoleucine, tryptophan, or phenylalanine. By having an amino
acid composition dominated by only a four letter code (G, S,
Q, and Y), the LC domain of FUS would appear to be more like
nucleic acids than typical proteins that fold into their ultimate,
three-dimensional shape by use of a much wider reliance on all
20 types of amino acid residues. When incubated at high con-
centrations, the LC domain of FUS has been found to polymerizeell 155, 1049–1060, November 21, 2013 ª2013 Elsevier Inc. 1049
Figure 1. Correlation Between Transcriptional Activation and
Hydrogel Binding of Native and Mutated Derivatives of the LC
Domain of FUS
(A) The LC domain of FUS was linked to the DNA-binding domain of GAL4 and
assayed for activation of a GAL4 reporter gene in transiently transfected U20S
cells. Activity of the native LC sequence was compared with 43 variants
wherein different number of tyrosine residueswere randomlymutated to serine
(see text). Identities of specific tyrosine-to-serine changes in each mutant are
shown in Table S1. Expression levels for all test protein were assayed by
western blotting as shown below histograms.
(B) The GFP-linked LC domains of FUS carrying the same mutations as (A)
were exposed to mCherry:FUS hydrogels (left) and initial binding rates were
measured (right).
(C) A correlation plot between the transactivation activity and hydrogel-binding
rate of the individual LC mutants. Note that there is but one significant outlier
indicated by a red circle. This is the ‘‘2A mutant’’ and described in more detail
in the text and Figure 5.
1050 Cell 155, 1049–1060, November 21, 2013 ª2013 Elsevier Inc.into uniform, amyloid-like fibers (Han et al., 2012; Kato et al.,
2012). Although morphologically similar to pathogenic amyloid
aggregates, polymeric fibers formed from the LC domain of
FUS are labile to depolymerization, raising the possibility that
reversible LC polymerization may engender functional utility.
Given twomeasurable features of the LC domain of FET proteins
(transcriptional activation capacity and polymerization propen-
sity), we hereby describe experiments that test the correlative
relationship between the two.
RESULTS
The FUS LC domain contains 27 repeats of the triplet sequence
[G/S]Y[G/S], and derivatives carrying 5, 9, 15, and 27 tyrosine-to-
serine mutations in randomly chosen triplets showed progres-
sively diminished capabilities of polymerization and stress
granule recruitment (Kato et al., 2012). In order to initiate studies
of the transcriptional activation capacity of the FUS LC domain, it
was linked to the GAL4 DNA-binding domain and assayed by
transient transfection for activation of firefly luciferase activity
driven by a GAL4-dependent reporter gene. Forty-three mutated
derivatives were preparedwherein individual tyrosine residues of
the triplet sequence within the LC domain were randomly
mutated to serine. Three mutants randomly changed a single
tyrosine, 6 changed two tyrosines, 9 changed three tyrosines,
12 changed four tyrosines, 7 changed five tyrosines, 4 changed
six tyrosines, 1 changed seven tyrosines, and 1 changed nine
tyrosines (Table S1). As shown in Figure 1A, concordance was
observed between the number of tyrosine residues changed to
serine and the degree of impediment upon of transcriptional
activation. With a single exception, variants carrying either one
or two tyrosine-to-serine changes exhibited transcriptional
activation capacity indistinguishable from the GAL4:wild-type
fusion protein. The exceptional variant (2A) was considerably
more active than the wild-type LC domain of FUS. Variants car-
rying three tyrosine-to-serine changes tended to be slightly less
active than those carrying zero, one or two mutations. The trend
in loss of activity was observed to track with variants carrying
four, five, or six random tyrosine-to-serine mutations, and
mutants carrying seven or nine tyrosine-to-serine mutations
revealed no detectable capacity to activate expression of the
GAL4-responsive luciferase target gene.
A simple assay for the propensity of LC domains to polymer-
ized into amyloid-like fibers has been described previously
(Kato et al., 2012). Briefly, upon prolonged incubation of a hybrid
protein linking the LC domain of FUS to mCherry, the protein
polymerizes into a hydrogel-like state. Microscopic gel droplets
can be formed in chamber slides, exposed to soluble test pro-
tein, then scored for trapping of the test protein via confocal
microscopy. The molecular basis of trapping has been deduced,
by TIRF microscopy, to result from copolymerization of the GFP-
tagged test protein into existing polymeric fibers in the mCherry:
FUS hydrogel droplets (Kato et al., 2012). Forty out of the 43 var-
iants described above were fused to GFP and tested for their
ability to be trapped by hydrogel droplets composed of mCherry
linked to the wild-type LC domain of FUS. As shown in Figure 1B,
variants carrying one or two tyrosine-to-serine changes were
trapped by the mCherry:FUS hydrogel droplets in a manner
similar to the protein linking the wild-type FUS LC domain
to GFP. Sequential diminishment in hydrogel trapping was
observed for variants carrying three, four, five, six, seven, or
nine tyrosine-to-serine mutations. The scatter plot shown in
Figure 1C directly compares the transcriptional activation and
hydrogel trapping capacities of all 40 mutants that were scored
in both assays. With the exception of the 2A mutant, which acti-
vates transcription considerably better than the wild-type LC
domain of FUS, a strong correlation was observed between
the two activities under study (Pearson’s r = 0.7 with a p value
of less than 0.0001). These data tentatively indicate that tran-
scriptional activation capacity of the LC domain of FUS may be
dependent upon its ability to polymerize.
B-isox Microcrystals Precipitate Nuclear Proteins
Having observed a correlative relationship between fiberization
and transcriptional activation capacity, we prepared nuclear ex-
tracts from HEK293 cells and subjected the lysate to precipita-
tion by the biotinylated isoxazole (b-isox) chemical. As described
previously, the b-isox chemical crystallizes in cold aqueous
buffer at concentrations between 30 and 100 mM (Kato et al.,
2012). X-ray diffraction studies at high resolution revealed the
b-isox crystal surface to contain a wavy repetition of peaks
and troughs separated by 4.7 A˚, and it has been hypothesized
that the troughs are properly disposed to capture proteins con-
taining significant stretches of random coil polypeptide. These
disordered, LC sequences are thought to adopt an extended
b strand conformation having dimensions that match the
trough of the b-isox crystal surface, thereby facilitating selective
precipitation of proteins endowed with substantive regions of
disordered polypeptide.
Given that earlier studies were limited to cytoplasmic lysates,
we prepared nuclear lysates from cultured mammalian cells,
precipitated with b-isox microcrystals, separated the precipi-
tated proteins on SDS polyacrylamide gels, and identified
precipitated proteins by shotgun mass spectrometry (Experi-
mental Procedures). Roughly 580 nuclear proteins were identi-
fied as being precipitated by b-isox microcrystals (Table S2).
This survey revealed overlap with many of the proteins precipi-
tated from cytoplasmic extracts by the b-isox chemical,
including many hnRNP proteins. Additionally, however, these
efforts revealed the identities of a number of nuclear proteins
not observed in earlier experiments that had interrogated cyto-
plasmic lysates. Prominent among the newly identified, b-isox
precipitated nuclear proteins were TAF15, the largest subunit
of RNA polymerase II, numerous subunits of the mediator com-
plex (including Med4, Med6, Med10, Med13L, Med 14, Med 15,
Med 17, and all subunits of CDK8), a variety of enzymes involved
in epigenetic modification of histones, both coactivator and
corepressor proteins known to control the function of nuclear
hormone receptors, and many distinct SR proteins known to
be involved in pre-mRNA splicing. Parallel studies were per-
formed on nuclear extracts prepared from Saccharomyces
cerevisae, leading to the identification of roughly 260 yeast
nuclear proteins significantly precipitated by the b-isox chemical
(Table S3). We again observed b-isox-mediated precipitation of
the largest subunit of RNA polymerase II. We also observed the
list of precipitated proteins to contain multiple subunits of theCmediator complex, and a number of gene-specific transcrip-
tion factors endowed with glutamine- and asparagine-rich,
low-complexity sequences.
With respect to nuclear proteins precipitated by the b-isox
chemical, our initial focus fell on TAF15 and the largest subunit
of RNA polymerase II. Among the 580 mammalian proteins
selectively precipitated by b-isox microcrystals, TAF15 regis-
tered the 23rd highest number of spectral counts, and the largest
subunit of RNA polymerase II registered the 46th highest number
of spectral counts (Table S2). B-isox precipitation of yeast
nuclear extracts also revealed the largest subunit of RNA
polymerase II as displaying an exceptionally high number of
spectral counts (Table S3).
TAF15 represents the third paralog of the FET family of RNA-
binding proteins and is endowed with an N-terminal LC domain
very similar to the LC domains found in FUS and EWS. Unlike
FUS and EWS, TAF15 has been identified as a substoichometric
component of the TFIID complex, which has been extensively
characterized as an important assembly in transcriptional initia-
tion by RNA polymerase II (Bertolotti et al., 1999). Attention to
the largest subunit of RNA polymerase II was prompted by the
fact that it contains an intrinsically disordered region of roughly
380 residues at its C terminus. This C-terminal domain (CTD) of
mammalian RNA polymerase II contains 52 heptad repeats of
the sequence Y1S2P3T4S5P6S7 (Corden et al., 1985). Extensive
work over the past two decades has confirmed the importance
of the CTD in the transcription cycle (Buratowski, 2009; Egloff
et al., 2012; Phatnani and Greenleaf, 2006). Included among
a variety of seminal advancements, the field now understands
that in its initial state of recruitment to a promoter, the CTD exists
in the unphosphorylated state. A series of obligatory phosphor-
ylation events on serine residues S2, S5 and S7 of the CTD heptad
repeats accompanies release of RNA polymerase from the pre-
initiation complex so that it can begin transcriptional elongation
(Egloff and Murphy, 2008). When aligned contiguously, the CTD
contains 52 repeats of the triplet sequence S7Y1S2 (or close var-
iations thereof). These repeats form a subset of the [G/S]Y[G/S]
repeats that we have found to be critical for polymerization of
the LC domain of FUS (Kato et al., 2012).
Phosphorylation of the CTD Blocks B-isox Precipitation
Using antibodies specific to either the unphosphorylated form
of the CTD of RNA polymerase II (8WG16), or antibodies to S2
phosphorylation (3E10), S5 phosphorylation (3E8), or S7 phos-
phorylation (4E12) (Chapman et al., 2007), we observed that
b-isox microcrystals preferentially precipitate only the unphos-
phorylated form of the yeast CTD (Figure 2). Parallel analyses
of b-isox precipitates from mammalian cells also revealed
selective precipitation of only the unphosphorylated form of the
largest subunit of RNA polymerase II (Figure S1A available
online). We tentatively hypothesize that the CTD is the determi-
nant of the largest subunit of RNA polymerase II that facilitates
b-isox precipitation, and that phosphorylation on residues S2,
S5 or S7 somehow impedes the ability of the CTD to fit within
the 4.7 A˚ surface troughs of b-isox microcrystals.
In order to test these ideasmore carefully, a GFP fusion protein
was prepared linked to heptad repeats 27-52 of the human
CTD (Experimental Procedures). The purified, recombinantell 155, 1049–1060, November 21, 2013 ª2013 Elsevier Inc. 1051
Figure 2. Biotinylated Isoxazole Preferentially Precipitates
Unphosphorylated CTD of RNA polymerase II
Western blot of total cell extract (T) or b-isox pellet (P) with different CTD
antibodies. Bands shown in the four panels correspond in size to the largest
subunit of RNA polymerase II (217 kD). The 8WG16 antibody recognizes the
unphosphorylated CTD, the 3E10 antibody recognizes serine 2 phosphory-
lated CTD, the 3E8 antibody recognizes serine 5 phosphorylated CTD, and the
4E12 antibody recognizes serine 7 phosphorylated CTD. B-isox significantly
precipitates only unphosphorylated CTD of Pol II. See also Figure S1.GFP:CTDC26 fusion protein was effectively precipitated by
b-isox microcrystals, yet phosphorylation of the CTD by either
CDK7, which phosphorylates S5 and S7 (Akhtar et al., 2009;
Kim et al., 2009; Rickert et al., 1999; Roy et al., 1994; Trigon
et al., 1998), or CDK9, which phosphorylates S2, S5 and S7
(Czudnochowski et al., 2012; Jones et al., 2004; Ramanathan
et al., 2001), prevented b-isox-mediated precipitation (Fig-
ure S1B). These observations confirm the CTD as the determi-
nant of the largest subunit of RNA polymerase II responsible
for b-isox precipitation and give evidence that when the CTD is
phosphorylated, precipitation is prevented.
Binding of the CTD to Hydrogel Droplets Composed of
FET Protein Polymers
Having recognized that the iterated S7Y1S2 triplet repeats of the
CTD correspond to a variant of the [G/S]Y[G/S] triplet repeats
diagnostic of the LC domains of FET proteins, we tested whether
the GFP:CTD fusion protein might bind to hydrogel droplets
formed from the LC domains of the three FET proteins (FUS,
EWS, and TAF15), as well as hydrogel droplets formed from
the LC domains of hnRNPA2 and cold inducible RNA-binding
protein (CIRBP). As shown in Figure 3A, the GFP:CTD fusion pro-
tein was avidly trapped by hydrogel droplets composed of the
LC domain of TAF15. No trapping whatsoever was observed
when the GFP:CTD test protein was exposed to either hnRNPA2
or CIRBP hydrogel droplets and weak trapping was observed for
FUS and EWS hydrogels.
GFP:CTD binding to TAF15 hydrogel droplets was extended
in two ways. First, we compared the binding properties of two
GFP test proteins, one containing 20 heptad repeats from the
highly conserved, N-terminal half of the CTD (repeats 1-20 =
GFP:CTDN20) and another containing 20 heptad repeats from
the degenerate C-terminal half of the CTD (repeats 33-52 =
GFP:CTDC20). As shown in Figure 3B, the GFP test protein ap-
pended to the 20 degenerate CTD repeats, GFP:CTDC20, bound
TAF15 considerably more avidly than the counterpart fusion
containing the 20 conserved CTD repeats (GFP:CTDN20). Sec-
ond, we compared hydrogel trapping for fusion proteins con-
taining 5, 10, 15, 20, or all 26 of the degenerate CTD repeats1052 Cell 155, 1049–1060, November 21, 2013 ª2013 Elsevier Inc.(GFP:CTDC5 = CTD repeats 48-52, GFP:CTDC10 = CTD repeats
43-52, GFP:CTDC15 = CTD repeats 38-52, GFP:CTDC20 = CTD
repeats 33-52, and GFP:CTDC26 = CTD repeats 27-52). As
shown in Figure 3C, no trapping by mCherry:TAF15 hydrogel
droplets was observed for the fusion protein containing only
5 heptad repeats, intermediate trapping was observed for the
fusion containing 10 heptad repeats, and equivalent trapping
was observed for fusions containing 15, 20, or 26 repeats.
When evaluating the kinetics of binding of the various
GFP:CTD constructs to hydrogel droplets composed of mCherry
linked to the LC domains of TAF15, FUS, or EWS, it was noticed
that gel trapping occurred more rapidly than the homo- or
heterotypic trapping of GFP fusion proteins linked to the LC
domains of FET proteins. Knowing that the latter trapping occurs
via a mechanism of copolymerization of soluble test proteins to
fibrous polymers of which the hydrogel droplets are themselves
composed (Kato et al., 2012), we employed fluorescence micro-
scopy to evaluate binding of the GFP:CTDC26 fusion protein to
fibrous preparations of mCherry:TAF15. As soon as the mixture
of the two protein samples could be applied to the microscope
substrate, clear evidence of GFP signal could be seen to coat
the entire length of mCherry:TAF15 polymeric fibers (Figure S2).
Instead of slow, time-dependent copolymerization extending
from either end of existing fibers, the GFP:CTDC26 protein rapidly
bound to the lateral surface of mCherry:TAF15 fibers. These
observations offer evidence of a second and distinct means by
which LC polymeric fibers are able to trap otherwise soluble
test proteins composed, in part, of LC domains. Theymay further
offer mechanistic insight into the perplexing promiscuity of
protein:protein interaction of intrinsically disordered proteins
(Cumberworth et al., 2013).
CTD Phosphorylation Blocks Hydrogel Binding
Knowing that phosphorylation of the CTD prevents precipitation
by b-isox microcrystals, we evaluated the effects of phos-
phorylation on trapping of GFP:CTD test protein by TAF15
hydrogels. When phosphorylated by either CDK7 or CDK9,
the GFP:CTD fusion protein was fully blocked from binding to
hydrogels composed of polymers of the LC domain of TAF15
(Figure S3). Emboldened by this observation, we prebound
the GFP:CTDC26 test protein to mCherry:TAF15 hydrogel drop-
lets then added either CDK7 or CDK9 in the presence of ATP. In
both cases, the GFP signal was lost in an enzyme concentra-
tion-dependent manner (Figure 4A). When applied at fixed
enzyme levels, the GFP signal diminished in a time and ATP-
dependent manner (Figure 4B). A video showing the dynamics
of GFP signal loss can be seen in Movie S1. Material released
from mCherry:TAF15 gel droplets in response to CDK7 was
recovered from the wells of chamber slides and evaluated by
western blotting using antibodies to both GFP and the S5 phos-
pho-form of the CTD. As shown in Figure 4C, both GFP and
phosphorylated CTD S5 western blotting signals were released
from the mCherry:TAF15 hydrogels as a function of enzyme
concentration. We conclude from these observations that not
only does phosphorylation of the CTD prevent binding to
mCherry:TAF15 hydrogels, but prebound material is accessible
to kinase-mediated phosphorylation and subsequent release
from the gels.
Figure 3. Selective Binding of GFP:CTD to
mCherry:TAF15 Hydrogel Droplets
(A)HydrogelscomposedofLCdomainsofmCherry:
TAF15, mCherry:FUS, mCherry:EWS, mCherry:
hnRNPA2 and mCherry:CIRP were incubated with
a soluble form of GFP linked to the C-terminal 26
heptad repeats of the CTD of mammalian RNA po-
lymerase II. Little or no retention of the GFP:CTDC26
protein was observed for the mCherry:hnRNPA2
or mCherry:CIRBP hydrogel droplets, and weak
binding was observed for mCherry:FUS and
mCherry:EWS hydrogels. By contrast, strong
retention was observed for mCherry:TAF15 hydro-
gel droplets. See also Figure S2.
(B) The degenerate C-terminal half of the CTD
(GFP:CTDC20) binds mCherry:TAF15 hydrogel
droplets more strongly than the highly conserved,
N-terminal half of the CTD (GFP:CTDN20).
(C) The binding intensity of the GFP:CTD
degenerate repeats to mCherry:TAF15 hydrogel
droplets correlates with the number of heptad
repeats, with no binding observed for GFP:CTDC5,
weak binding for GFP:CTDC10 and strong binding
for GFP:CTDC15, GFP:CTDC20 and GFP:CTDC26.The 2AMutant of the FUS LCDomain Displays a Gain-of-
Function Phenotype
In comparing the properties of mutants of the LC domain of FUS
with respect to both fiber polymerization and transcriptional acti-
vation (Figure 1), we observed significant discordance for only
one mutant. The so-called ‘‘2A mutant’’ bound to mCherry:FUS
hydrogel droplets with avidity indistinguishable from the wild-
type protein, yet activated transcription considerably better
than the normal LC domain of FUS. Hydrogel droplets were
formed from a fusion protein linking the 2A mutant to mCherry,
fully analogous to the wild-type protein linked to mCherry save
for the two tyrosine-to-serine changes. When challenged with
the different heptad repeats of GFP:CTD test proteins, signifi-
cantly stronger gel trapping was observed for hydrogel droplets
formed from the 2A mutant LC domain (Figure 5A). We conclude
that polymeric fibers formed from the 2A mutant bind the
unphosphorylated CTD better than the wild-type LC domain of
FUS, and offer the hypothesis that this gain-of-function pheno-
type may explain why the 2A mutant activates transcription bet-
ter than the wild-type LC domain of FUS (Figure 1). Despite the
enhanced binding of the 2Amutant to various GFP:CTD test pro-
teins, the latter interactions were blocked by CDK7- or CDK9-
mediated phosphorylation (Figure S4A). Moreover, application
of either of these protein kinase enzymes, in the presence of
ATP, caused prebound GFP:CTDC26 protein to be released
from hydrogel droplets composed of LC domain prepared from
the 2A mutant in a manner indistinguishable of CTD release
from hydrogel droplets formed from the wild-type LC domain
of FUS (Figure S4B).
An alignment of the 27 [G/S]Y[G/S] triplet repeats located
within the LC domains of FUS and TAF15 is shown in Figure 5B.
The two tyrosine residues mutated to serine in the 2A, gain-of-
function variant, correspond to tyrosine residues embedded
within the 16th and 20th [G/S]Y[G/S] triplets of the FUS LC
domain. In comparing this region of the two LC domains, FUS
that when polymerized binds the CTD weakly, and TAF15 thatCbinds the CTD avidly, we notice that triplet repeats 16-21 of
the TAF15 LC domain are unusual. Instead of the central tyrosine
residues being flanked by either glycine or serine, six straight
repeats bear an aspartic acid residue on one side of the central
tyrosine or the other (SYD16, DYG17, SYD18, GYD19, SYD20, and
NYD21). As will be discussed, this ‘‘16-21 window’’ may be
worthy of close attention with respect to the ability of the LC do-
mains of FET proteins to capture the CTD of RNA polymerase II.
DNA-Mediated Enhancement of FET Protein
Polymerization
The test tube polymerization of the LC sequences associated
with FET proteins is only observed at high concentrations
(Kato et al., 2012). One means by which appropriately high con-
centrations necessary for polymerization could take place in
living cells is if FET proteins are iteratively bound to a multivalent
substrate. ChIP-chip experiments have given evidence that
when the LC domain of EWS is linked to the FLI DNA-binding
domain, it binds in living cells to microsatellites carrying iterative
repeats of the tetranucleotide sequence GGAA (Gangwal et al.,
2008). Since GGAA represents an optimal binding site for the
ETS DNA-binding domain of the EWS:FLI protein, the fusion pro-
tein binds iteratively to these otherwise inert microsatellites. If
located within 5-10 kb of a target promoter, the translocation
product-bound microsatellite is envisioned to become a rogue
enhancer. Under such a setting, it is possible that the LC
domains of the densely packed EWS:FLI molecules can be
prompted to polymerize.
As a test of this hypothesis, microsatellite sequences asso-
ciated with the hNR0B1 gene were amplified by PCR from
U2OS cells (Experimental Procedures). A PCR product contain-
ing 25 repeats of the GGAA tetranucleotide was incubated with a
recombinant protein linking mCherry to a fusion protein
composed of the DNA-binding domain of FLI attached to the
LC domain of FUS (Experimental Procedures). In the absence
of added DNA, the 0.5 mM levels of the mCherry:FUS-FLI proteinell 155, 1049–1060, November 21, 2013 ª2013 Elsevier Inc. 1053
Figure 4. CDK7-Mediated Release of
GFP:CTDC26 from mCherry:TAF15 Hydrogel
Droplets
(A) The GFP:CTDC26 trapped by mCherry:TAF15
hydrogel was released upon addition of CDK7 or
CDK9 in the presence of ATP in an enzyme con-
centration-dependent manner.
(B) Hydrogel droplets of mCherry:TAF15 (red)
were exposed to GFP:CTDC26 (green). Chamber
slides containing individual hydrogel droplets
were exposed to CDK7 plus ATP (top row), CDK7
alone (middle row), or ATP alone (bottom row).
Samples exposed to both CDK7 and ATP revealed
the time-dependent release of GFP:CTDC26. See
also Movie S1.
(C) Western blot analysis of materials released into
the well of chamber slides revealed progressive
increases in the presence of soluble, phosphor-
ylated CTD (top), and soluble GFP:CTDC26
(bottom).
See also Figure S3.remained in a largely disaggregated state as deduced by trans-
mission electronmicroscopy (Figure 6B). By contrast, addition of
the PCRproduct containing the iterative GGAA repeats led to the
formation of an extensive network of interwoven fibers (Fig-
ure 6A). When evaluated by a gel mobility shift assay, it was
apparent that multiple copies of the mCherry:FUS-FLI protein
were simultaneously bound to the probe DNA containing
iterative repeats of the GGAA tetranucleotide (Figure S5). We
tentatively conclude that when multiple copies of the mCherry:
FUS-FLI protein are simultaneously bound to DNA, polymeriza-
tion of the LC domain of FUS is enhanced.
Polymerization-Dependent CTD Binding to the LC
Domain of TAF15
Hydrogel droplets formed from a fusion protein linking mCherry
to the amino terminal 208 residues of TAF15 bind a variety of
GFP:CTD constructs, particularly those housing 15 or more of
the degenerate, C-terminal heptad repeats (Figure 3C). A trun-
cated version of the TAF15 LC domain restricted to 80 amino-
terminal residues was observed to form hydrogel droplets
equally as well as the intact LC domain, yet was only minimally
capable of trapping the GFP:CTDC10 and GFP:CTDC20 con-
structs (Figure S6). Addition of the remaining 128 residues of
the LC domain yielded a protein that readily formed hydrogels
that trapped the GFP:CTD constructs avidly.
These observations hint to the possibility that the amino termi-
nal half of the TAF15 LC domain may be critical for polymeriza-
tion, and that the carboxyl terminal half might be critical for
CTD binding. Proceeding with this idea, a series of 48 variants
was prepared wherein between one and six tyrosine residues
of the [GS]Y[GS] triplet repeats were randomly mutated to serine
(Table S4). Each mutant was linked to the DNA-binding domain
of GAL4 and tested for its ability to activate the GAL4-luciferase
reporter gene. As shown in Figure 7A, all six variants carrying a
single tyrosine-to-serine mutation were less competent in tran-
scription activation capacity than the wild-type protein. Variants1054 Cell 155, 1049–1060, November 21, 2013 ª2013 Elsevier Inc.carrying two, three, four, five, or six random tyrosine-to-serine
mutations suffered sequentially diminished activity. Three of
the 48 mutants were chosen for further study. These include
the 1F, 2H, and 3K mutants, all of which were among the most
debilitated variants within their respective classes. All of the tyro-
sine residues altered in these particularly deleterious mutants
localized to the first 80 residues of the TAF15 LC domain that,
on its own, is capable of fiberization and hydrogel formation.
The 1F mutant changes tyrosine 46 to serine, the 2H mutant
changes tyrosines 38 and 56 to serine, and 3K changes tyrosines
17, 46, and 63 to serine (Table S4).
The TAF15 LC domains of these variants were linked to
mCherry and compared to the wild-type LC domain with respect
to hydrogel formation, fiberization, and CTD interaction. None of
the mutants formed hydrogels when incubated under standard
conditions (Movie S2). When incubated under conditions favor-
able for fiberization, the mCherry variant linked to the wild-type
LC domain of TAF15, as visualized by fluorescence microscopy,
formedobvious tangles of aggregated fibers. Almost nopolymer-
ization was observed for the 1F, 2H, and 3K mutants. Inspection
of the rare occurrence of visible mCherry aggregates in the latter
variants revealed small amorphous particles (Figure 7B). Finally,
when mixed with the GFP:CTDC26 construct and subjected to
coimmunoprecipitation, no interactionwhatsoeverwasobserved
for anything but themCherry fusion protein linked to the native LC
domain of TAF15 (Figure 7C). These and other data presented
herein give evidence that the LC domains of FET proteins obliga-
torily rely upon polymerization in order to execute their role in
transcriptional activation. Whether LC domain polymerization
mightbemorebroadly employed in thecontext of gene regulation
in eukaryotic cells remains open to question.
Schematic Concept of RNA Polymerase Recruitment by
LC Domain Polymers
Cancer cells expressing the translocation product wherein the
LC domain of EWS is linked to the ETS DNA-binding domain of
Figure 5. Hydrogels Formed from the 2A
Mutant of FUS LC Domain Display
Enhanced CTD Binding
(A) 2A mutant of FUS LC domain, which exhibits
enhanced transactivation activity relative to the
wild-type protein (Figure 1C), carries tyrosine-to-
serine mutations at tyrosine within the 16th and
20th [G/S]Y[G/S] triplet repeats (Figure 5B). The 2A
mutant LC domain was fused with mCherry, and
hydrogel-binding assays were carried out with
GFP:CTD fusions carrying different numbers of
heptad repeats. Compared with hydrogel droplets
formed with the native LC domain of FUS, those
formed from the 2A mutant showed enhanced
binding to GFP:CTDC20 and GFP:CTDC26. See
also Figure S4.
(B) Alignment of [G/S]Y[G/S] triplet repeats in low-
complexity domains of FUS (left) and TAF15 (right).
The two tyrosine-to-serine mutations causing FUS
to suffer a gain-of-function enhancement in tran-
scriptional activation and CTD binding are high-
lighted in blue. All triplet repeats of TAF15 carrying
an aspartic acid or glutamic acid adjacent to
tyrosine are highlighted in green. Canonical [G/S]Y
[G/S] triplet repeats of both LC domains are shown
in red.FLI depend upon this fusion protein to drive cell growth or
survival. The EWS:FLI translocation product is undoubtedly
employed as an aberrant transcription factor required to repro-
gram gene expression in a manner beneficial to cancer cells.
We hypothesize that upon binding to the relevant sites on
DNA, including microsatellites bearing iterative repeats of the
tetranucleotide sequence GGAA, the EWS:FLI fusion protein
can polymerize via its LC domains. As depicted schematically
in (D) of Figure 7, we further hypothesize that fibrous polymers
of the LC domain create binding sites for the CTD of RNA poly-
merase. Finally, we predict that phosphorylation of the CTD by
CDK7, CDK9, or a related protein kinase enzyme facilitates
release of the polymer-bound RNA polymerase so that it can
escape gene promoters and enter into the process of transcrip-
tional elongation.
DISCUSSION
Here, we report evidence that the LC domains of FET proteins
may require polymerization as a means of directly capturing the
CTD of RNA polymerase II. If correct, these data lend credence
to the hypothesis advanced by Kato, Han, and colleagues (Han
et al., 2012; Kato et al., 2012). The thesis of the initial studies on
b-isox precipitation, LC sequences, LC polymerization, and LC-
derived hydrogels offered the concept that intrinsically disor-
dered domains associated with RNA regulatory proteins and
transcription factors might reversibly polymerize as a means of
helping establish cellular organization and information flow from
DNA to RNA to protein. The present study extends earlier work
in several ways. First, by having a simple functional read-out
(transcriptional activation), we have been able to establish a
pattern of significant concordance between the capacity of LC
domains to polymerize and their ability to function as transcrip-Ctional activation domains (Figure 1). Indeed, the single most
discordant mutant (the 2A mutant) was found to suffer a gain-
of-function phenotype in transcriptional activation capacity that
may be attributable to its enhanced capacity to bind the CTD of
RNA polymerase II. Second, we offer the simple conclusion
that, when appended to a DNA-binding domain as a function of
scores of independent cancer-causing translocation events,
the LC domains of FET proteins act to directly recruit the CTD
of RNA polymerase II (Figure 3). In order to achieve this task,
the LC domains of FET proteins must be capable of polymeriza-
tion (Figure 7). Whereas the hydrogel droplets deployed as our
mainstay assayare composedof long fiberouspolymers contain-
ing thousands of subunits, we have no idea as to howmany sub-
units must polymerize as a ‘‘point source’’ to recruit the CTD of
RNA polymerase. It is entirely possible that fiberous seeds
composed of only a handful of LC domain subunits might be suf-
ficient to nucleate functionally competent organizational puncta.
Evidence that the LC domains of FET proteins are able to
interact with the CTD of RNA polymerase II is consistent with
recent studies of FUS in its native form (Schwartz et al., 2012).
The latter study provided compelling evidence for direct interac-
tion between the CTD of RNA polymerase II and the intact FUS
protein. Intriguingly, this interaction was shown to be RNA
dependent. In a new study, Cech and colleagues offer exciting
data that may explain RNA dependence (Schwartz et al.,
2013). Since the intact FUS protein is endowed with an RNA-
binding domain, addition of an RNA polymer offers the opportu-
nity for FUS to bind multiple times to the RNA substrate, thereby
bringing LC domains of multiple protomers into proximity, and
thereby enhancing local concentration and the propensity of
the LC domains to polymerize.
Similar phenomena may well be in play in the context of trans-
location products carrying the LC domains of FET proteins fusedell 155, 1049–1060, November 21, 2013 ª2013 Elsevier Inc. 1055
Figure 6. DNA-Dependent Enhancement of
Fiber Formation of FUS-FLI Fusion Protein
(A) mCherry:FUS LC domain-FLI DNA-binding
domain fusion protein (0.5 mM) was incubated with
microsatellite DNA (20 nM) in the presence of 35%
glycerol. After 1 hr incubation, materials in the
solution were visualized by transmission electron
microscopy. FUS-FLI fibers grew long and
became large sleave.
(B) mCherry:FUS-FLI protein was incubated in the
presence of 35% glycerol (no DNA). Small
amounts of spontaneous nucleation and fiber
growth were observed. All scale bars indicate
0.5 mm.
See also Figure S5.to different DNA-binding domains. Beautiful ChIP-chip experi-
ments have given evidence that when the LC domain of EWS
is linked to the FLI DNA-binding domain, it binds in living cells
to microsatellites carrying iterative repeats of the tetranucleotide
sequence GGAA (Gangwal et al., 2008). Since GGAA represents
an optimal binding site for the ETS DNA-binding domain of the
EWS:FLI protein, the fusion protein binds iteratively to these
otherwise inert microsatellites. If located within 5–10 kb of a
target promoter, the translocation product-bound microsatellite
has been hypothesized to become a rogue enhancer. We are
like-minded with the Cech lab in providing evidence that
enhanced local concentration via proximal binding of multiple
subunits of LC domain containing proteins will represent a crit-
ical stimulus for polymerization (Figure 6).
Despite coming to similar conclusions regarding LC polymer-
ization and CTD binding, the Cech studies differ in many
ways from those reported herein. Cech and colleagues have
employed intact FUS protein and have studied the protein in
the context of its normal cellular function. We, instead, have
focused on the isolated parts of FET proteins that are translo-
cated in cancer onto a variety of DNA-binding domains. It is rela-
tively straightforward to conceptualize how the latter class of1056 Cell 155, 1049–1060, November 21, 2013 ª2013 Elsevier Inc.proteins bind DNA, polymerize locally
via their LC domains, and thereby
achieve the fibrous organizational state
required to bind the CTD of RNA poly-
merase II. How, instead, might one
conceptualize the manner in which
native, RNA-binding forms of FET pro-
teins achieve the same task? One possi-
bility is that native FET proteins are able
to bind to noncoding RNAs that remain
nascently attached to DNA. Perhaps
these complexes might function as
‘‘RNA enhancers,’’ (Kim et al., 2010;
Lam et al., 2013; Li et al., 2013; Wang
et al., 2011) achieving the goal of bringing
FET proteins into the proximity of target
genes at locally elevated protein concen-
trations adequate to facilitate LC domain
polymerization necessary for the recruit-
ment of RNA polymerase II.Even if both of these conceptualizations of polymer-depen-
dent CTD recruitment are fundamentally correct, we are un-
doubtedly only beginning to see the tip of the iceberg. Hundreds
of RNA regulatory proteins and transcription factors contain LC
domains, offering almost limitless opportunity for complexity in
cellular organization—including the possible existence of solid-
state polymeric pathways for information flow from ‘‘transcrip-
tion factories’’ through fibrous nuclear bodies into various forms
of cytoplasmic RNA granules to the ultimate sites of mRNA
translation. Anticipating that LC domains are almost certainly
regulated by posttranslational modification, it is clear that we
are at the earliest stage of recognizing this new and unconven-
tional way of thinking about cellular organization. Indeed, if we
are correct in assuming that phosphorylation of the CTD of
RNA polymerase II triggers its release from FET protein fibers,
this may serve as an initial paradigm for considering post-
translational modification as a means of controlling the dynamic
behavior of LC derived polymers.
We close with three perplexing observations. First, why do
polymeric fibers formed from the LC domain of TAF15 bind the
CTD so much more avidly than the analogous LC domains of
FUS and EWS (Figure 3A)? Second, why is it that mutations of
Figure 7. Polymerization of the LC Domain
of TAF15 is Required for Both Transcrip-
tional Activation and CTD Binding
(A) Forty-eight tyrosine-to-serine mutations were
randomly introduced into the LC domain of TAF15
(Table S4). Mutants were assayed for transcrip-
tional activation capacity as GAL4 fusion proteins.
Expression levels for individual test proteins were
monitored by western blotting as displayed below
histogram depictions of transcriptional activation
measurements.
(B) mCherry fusion proteins linked to the native LC
domain of TAF15 (WT), the 1F mutant, the 2H
mutant, and the 3K mutant were incubated under
conditions favorable for polymerization (Experi-
mental Procedures). Fluorescence microscopy
was employed as an assay for fiberization of the
four test proteins. See also Movie S2.
(C) Coimmunoprecipitation assays were con-
ducted by mixing Flag-tagged GFP:CTDC26 with
HA-tagged versions of mCherry linked to the
native form of the TAF15 LC domain, or to the 1F,
2H or 3K tyrosine-to-serine mutants. Following
HA-mediated immunoprecipitation, samples were
run on a denaturing SDS-PAGE gel and subjected
to western blotting using either anti-Flag or anti-
HA antibodies. See also Figure S6.
(D) Schematic Concept of RNA Polymerase II
Recruitment by LC Domain Polymers. (1) The CTD
of RNA polymerase II does not bind to monomers
of the unstructured LC domain of FET protein
fused to the ETS DNA-binding domain. (2) Once
the ETS DNA-binding domain of the fusion pro-
tein binds to the GGAA repeats on microsatellite
DNA, the LC domains of FET protein form fibrous
polymer that can recruit RNA polymerase II via
direct interaction with the CTD. (3) Phosphoryla-
tion of serine residues 2, 5, and 7 of the CTD
heptad repeats by CDK7 or CDK9 facilitates
release of RNA polymerase II from the FET LC
domain polymer.two tyrosines in the LC domain of FUS yield a protein with
enhanced transcriptional activation capacity and an enhanced
ability to bind the CTD of RNA polymerase II (Figures 1 and 5)?
Third, why do the degenerate CTD repeats bind the polymeric
fibers of FET LCdomains better than the consensus repeats (Fig-
ure 3B)? Since TAF15 was discovered as a component of the
TFIID complex, one might imagine that its function has become
more proximally evolved to the transcription initiation process
than FUS or EWS, thus consistent with constitutive, avid affinity
for the CTD of RNA polymerase II. The region of TAF15’s LC
domain most distinctly different from the LC domains of FUS
and EWS is in the [G/S]Y[G/S] repeats 16-21, precisely the
same region of the location of the two tyrosine-to-serine muta-
tions in the 2A gain-of-function mutant of FUS (Figure 5). Six
straight repeats of TAF15 contain aspartic acid on one side or
the other of the central tyrosine.We speculate that these aspartic
acid residues disrupt or in some way modify the TAF15 poly-
meric fiber in this region, and that such modifications enhance
CTD binding. Likewise, we hypothesize that the two tyrosine-
to-serine alterations in the 2A mutant of the FUS LC domain
also modify the polymeric fiber in a manner favoring CTD bindingCand transcriptional activation capacity. Perhaps FUS and EWS
can be modified by phosphorylation on serine residues flanking
the tyrosines in this ‘‘16-21 window’’ of their LC domains, such
that fiber disruption and propensity for CTD binding might be
controlled in a regulated manner—rather than being ‘‘hard-
wired’’ as is possible owing to TAF15’s evolutionary accumula-
tion of aspartic acid residues as phosphomimetics.
Finally, we consider why it might be that the polymeric form of
the TAF15 LC domain binds the C-terminal degenerate CTD
repeats so much more strongly than the N-terminal consensus
CTD repeats (Figure 3B). The N-terminal consensus repeats of
the CTD have been shown to bind and cocrystallize with compo-
nents of the mediator complex (Robinson et al., 2012). Likewise,
elegant EM studies have also provided evidence of CTD:media-
tor interaction (Tsai et al., 2013). Perhaps upon evolutionary
duplication of the CTD from 26 repeats in yeast to 52 repeats
in mammals has allowed the degenerate repeats to adopt a
new function molded to the fibrous LC domains of FET proteins.
Close inspection of the degenerate repeats may be revealing in
this regard. In comparing the degenerate repeats to our most
distant evolutionary relative bearing the degenerate repeats,ell 155, 1049–1060, November 21, 2013 ª2013 Elsevier Inc. 1057
teleost fish from which humans diverged 450 million years ago, it
is notable that the pattern of degeneracy is nearly identical.
Briefly put, the degenerate changes installed nearly one half
billion years ago have been perfectly conserved. The most
notable difference between the degenerate and consensus
CTD repeats is the presence of lysine residues replacing S7 (Y1
S2P3T4S5P6S7 versus Y1S2P3T4S5P6K7) in seven of the degen-
erate repeats. Although embarrassingly simplistic, we speculate
that the positive charge of these seven lysine residues on the
immediate N-terminal sides of tyrosines in the degenerate CTD
repeats might blend with the negative charge of six consecu-
tive aspartic acids flanking tyrosines in the ‘‘16-21 window’’ of
TAF15. If correct, this idea of charge attraction might explain
the longstanding enigma of acidic activation domains.
EXPERIMENTAL PROCEDURES
Materials
Synthesis of the biotinylated isoxazole is described previously (Kato et al.,
2012). Mammalian pM expression vector was purchased from Clontech Lab-
oratory (USA). CDK7/Cyclin H/MAT1 and CDK9/Cyclin T1 enzyme complexes
were purchased from Millipore.
Transcriptional Activation by Tyrosine-to-SerineMutants of FUSand
TAF15 LC Domain
Mammalian expression plasmids for human FUS or TAF15 LC domain fused to
GAL4 DNA-binding domain were constructed by insertion of a DNA fragment
encoding FUS LC domain (residues 2-266) or TAF LC domain (residues 2-208)
into the multiple cloning sites of pM vector (Clontech, USA). Tyrosine-to-
serine mutants of GAL4-FUS LC and GAL4-TAF15 LC were generated by
QuickChange Multi Site-Directed Mutagenesis Kit (Agilent Technologies). To
test transcriptional activity of GAL4-fused LC domains, luciferase assays
were performed in quadruplicate in 96-well plate. In each well, 50 ng of
pM-LC vector and 20 ng L8G5-Luc (Lemercier et al., 2000) were reverse trans-
fected to HEK293T cells (6,500 cells per well) by lipofectamine 2000 (Invitro-
gen). Luciferase assayswere performed after 24 hr of incubation at 37C, using
Bright-Glo Luciferase Assay System (Promega). In order to obtain similar
protein levels relative to wild-type, 25 ng, 50 ng, or 100 ng of pM-LC mutant
plasmids were cotransfected with L8G5-Luc, and expression of GAL4-fused
LC domains was determined by western blotting with anti-GAL4 antibody
(sc-510, Santa Cruz Biotechnology). The DNA dosages yielding the same
expression level of GAL4-FUS mutant proteins to the wild-type protein were
used for luciferase assays.
Generation of Bacterial Expression Constructs
Expression plasmids for recombinant proteins used in all the biochemical
assays were constructed using pHis-parallel vectors (Sheffield et al., 1999)
as described before (Kato et al., 2012). The details were described in Supple-
mental Information.
Protein Purification
All recombinant proteins were overexpressed in E. coli strain BL21(DE3).
mCherry and GFP fusion LC domains from FUS, EWS, TAF15, CIRBP and
hnRNPA2 were expressed and purified as described previously (Kato
et al., 2012). GFP:CTD proteins were purified by Ni-NTA (QIAGEN, USA) in
the same conditions described previously (Kato et al., 2012), and further
purified by a Hi-Load Superdex 200 gel filtration column (GF Healthcare,
USA). The expression and purification of his-tagged mCherry:FUS LC
domain-FLI DNA-binding domain fusion protein is described in Supplemental
Information.
Hydrogel-Binding Assays
Hydrogel droplets of mCherry:LC domain of either FUS, EWS, TAF15, CIRBP,
or hnRNPA2 were prepared as described before (Kato et al., 2012). Briefly,1058 Cell 155, 1049–1060, November 21, 2013 ª2013 Elsevier Inc.concentrated mCherry fusion proteins (typically 50 mg/ml) were dialyzed in
gelation buffer containing 20 mM Tris-HCl (pH 7.5), 200 mM NaCl, 20 mM
BME, 0.5 mM EDTA, 0.1 mM PMSF over night. Dialyzed protein solution
was sonicated, clarified by centrifugation, and concentrated again to
50–80 mg/ml. Small droplets (0.5 mL) of this protein solution were placed
on a glass-bottomed dish (MatTek, USA). Hydrogels typically form after incu-
bation for a couple of days at room temperature. For standard hydrogel-bind-
ing assays, glycerol stocks of the purifiedGFP fusion test proteins were diluted
to 1 mM in 1 ml of the gelation buffer. The GFP test solution was pipetted into
the hydrogel dish so as to soak the hydrogel droplets in the GFP solution. After
overnight incubation at 4C, a horizontal section of the hydrogel droplet was
scanned with both the mCherry and GFP excitation wavelengths on a Zeiss
LSM510 confocal microscope. To measure binding rates of the FUS LC
domain mutants carrying different number of tyrosine-to-serine mutations
onto the wild-type mCherry:FUS hydrogels, immediately after GFP:mutant
solution was administered into the hydrogel dish, scans of a horizontal section
of the hydrogel droplet were performed at indicated time points. GFP signals of
the scanned sections were integrated by the program ImageJ (Rasband, 1997-
2011). Initial binding rates were calculated by a linear regression fitting with the
program Prism (Graphpad, USA). The scatter plot for calculating correlation
between transactivation and hydrogel binding rate of the mutants was made
using the program Prism.
Cyclin-Dependent Kinase Assay
For release of GFP:CTDC26 from mCherry:TAF15, mCherry:FUS and
mCherry:FUS 2A hydrogels by phosphorylation, unphosphorylated
GFP:CTDC26 was preincubated with the hydrogels overnight. After removing
the GFP:CTDC26 solution, the CDK7 or CDK9 reaction mixtures were applied
to the GFP:CTDC26-trapped hydrogel droplets. The hydrogel plates were
incubated at 30C for 1 hr. Hydrogels were analyzed by a confocal
microscope. For western blotting of the released protein from the hydrogel
droplets, the reaction mixture was carefully removed from the hydrogel plate
and mixed with 2 3 SDS lysis buffer. After SDS-PAGE, GFP:CTDC26 protein
was transferred to a nitrocellulose filter and visualized by western blotting
using anti-GFP antibodies (Chemicon) or the 3E8 phospho-S5 antibody
(Millipore).
Biotinylated Isoxazle-Mediated Precipitation
Protein precipitation by b-isox chemical from yeast extract and human nuclear
extract is described in Supplemental Information.
Cloning of Microsatellite DNA
Themicrosatellite DNA in the promoter region of the hNROB1 gene was ampli-
fied by PCR from U2OS cell genomic DNA as a template. The sequence of the
microsatellite DNA is shown in Supplemental Information.
Transmission Electron Microscopy
DNA-dependent fiber formation of mCherry:FUS-FLI protein was carried out in
a reaction mixture containing 20 mM Tris-HCl (pH 7.5), 200 mM NaCl, 20 mM
BME, 0.5 mM EDTA, 0.1 mM PMSF, and 35% glycerol, with or without 20 nM
microsatellite DNA. mCherry:FUS-FLI protein stored in 50% glycerol was
added to the reaction mixture at the final concentration of 0.5 mM, and the
reactions were incubated at room temperature for 1 hr. The sample solution
(10 mL) was spotted on a TEM grid (FCF-200-Cu Copper grid from Electron
Microscopy Sciences, USA). After blotting the excess solution, the surface
of the grid was washed with 10 ml distilled water twice. After removing the
excess water, the grid was stained for 10 s with 10 ml drop of 2% uranyl acetate
in water. After the uranyl solution was blotted, the grid was dried in air. TEM
images were obtained at 120 kV on Tecnai TEM.
Fiber Extension Assays
The mCherry:TAF15WT, 1F, 2H, or 3K protein solution (100 mM) in the gelation
buffer was sonicated to break down the preformed fibers, if any, into short fiber
seeds. After spin down at 14K rpm for 5 min at 4C, the protein solution was
transferred to new test tubes. After overnight incubation at 4C, the proteins
were 10-fold diluted in the gelation buffer and the formed fibers were detected
by fluorescence microscopy.
Pull Down of GFP:CTDC26 by mCherry:TAF15
HA- or Flag-tag was added, respectively, to the C terminus of mCherry:TAF15
or GFP:CTDC26 by PCR amplification. mCherry:TAF15 WT, 1F, 2H, or 3K-HA
proteins were diluted to 10 mM in gelation buffer with 0.05% NP-40. After
4 hr of incubation at 4C, 1 mM of GFP:CTDC26-Flag and 10 ml of HA-magnetic
beads (Pierce, USA) were added to each tube containing mCherry:TAF15 so-
lution. The mixtures were incubated for overnight at 4C with gentle rotation.
The magnetic beads were washed twice with the gelation buffer with
0.05% NP-40. Protein was recovered by boiling at 95C for 10 min in 23
SDS lysis buffer. Protein was visualized by western blotting using Flag or HA
antibodies.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, four tables, and two movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2013.10.033.
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